Verteporfin with altered (delayed) light in occult CNV (VALIO) - Results of a phase II controlled clinical trial

被引：0

作者：

Slakter, JS

Rosenfeld, PJ

机构：

[1] Bascom Palmer Eye Inst, Miami, FL 33136 USA

[2] Vitreous Ret Mac Consult NY, New York, NY USA

来源：

INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2003年 / 44卷

关键词：

D O I：

暂无

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

1101

引用

页码：U297 / U297

页数：1

共 50 条

[1] Verteporfin with altered (delayed) light in occult (VALIO) - 12-month results of a phase II controlled clinical trial
Singerman, LJ
Rosenfeld, P
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U904 - U904
[2] Verteporfin in occult (VIO): The design of a phase III controlled clinical trial of verteporfin therapy for occult with no classic subfoveal CNV secondary to AMD
Kaiser, PK
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U904 - U904
[3] Verteporfin in minimally classic CNV due to AMD (VIM) - Two-year results from a phase II controlled clinical trial
Rosenfeld, P
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U904 - U904
[4] Verteporfin therapy of subfoveal occult choroidal neovascularization in AMD using delayed light application: One-year results of the VALIO study
Rosenfeld, Philip J.
Boyer, David S.
Bressler, Neil M.
Fish, Gary
Grizzard, W. Sanderson
Hao, Yong
Hnik, Peter
Hudson, Henry L.
Singerman, Lawrence
Slakter, Jason S.
Grp, V. A. L. I. O. Study
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2007, 144 (06) : 970 - 972
[5] Verteporfin PDT for subfoveal occult CNV in AMD: two-year results of a randomized trial
Kaiser, Peter K.
CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (08) : 1853 - 1860
[6] Verteporfin therapy with delayed light application for the treatment of occult choroidal neovascularization (CNV) in age-related macular degeneration (AMD)
Rosenfeld, PJ
Suner, I
Cruz-Villegas, V
Villate, N
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U215 - U215
[7] A phase II placebo-controlled, double-masked, randomized trial - Verteporfin in minimally classic CNV due to AMD (VIM)
Bressler, NM
Rosenfeld, PJ
Lim, JI
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U297 - U297
[8] Verteporfin early retreatment (VER) - 12-month results of a phase IIIb controlled clinical trial
Stur, M
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U904 - U904
[9] Cytomegalovirus vaccine: phase II clinical trial results
Rieder, F.
Steininger, C.
CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 : 95 - 102
[10] Results published on Phase II clinical trial for dengue vaccine
O'Hare, Alice
EXPERT REVIEW OF VACCINES, 2012, 11 (11) : 1287 - 1287

← 1 2 3 4 5 →